How much should you trust the results of a rapid antigen test? Researchers are working hard to figure out what's going on with the tests and how to improve them.
- January 18, 2022
SalivaDirect at the Yale School of Public Health provides thousands of COVID-19 tests to hundreds of people with support from The Rockefeller Foundation.
- January 14, 2022Source: The New York Times
As Omicron spreads, some experts are calling for a switch to saliva-based tests, which may detect infections days earlier than nasal swabs do.
- January 11, 2022Source: National Geographic
This variant is more transmissible. So how do you protect yourself? And what are the implications for vaccines, masks, hygiene, and social distancing?
- January 06, 2022Source: Popular Science
Standard-issue antigen tests missed every COVID case in the first days of an infection, at a time when people were demonstrably infectious.
- January 05, 2022Source: The New York Times
A new study adds to evidence that common rapid tests may fail to detect some Omicron cases in the first days of infection.
- December 01, 2021
A Yale School of Public Health student is helping the U.S. government set up COVID-19 screening programs in K-12 schools across the country.
- November 09, 2021Source: Yale Daily News
SalivaDirect, a Yale-created protocol that allows for greater efficiency in COVID-19 testing, has received FDA emergency use authorization to be used for pooled COVID-19 virus testing of up to five individual samples at a time.
- November 03, 2021Source: Technology Networks Diagnostics
The U.S. Food and Drug Administration (FDA) has authorized the SalivaDirect PCR COVID-19 test created by the Yale School of Public Health for use with pooled saliva samples.
- November 01, 2021Source: YaleNews
Pooled testing allows labs to combine saliva samples from multiple individuals into a single tube and process the batch as a single test. This approach maintains clinical sensitivity while enabling labs to process tests far more quickly.